ClinicalTrials.gg
Sign In

Loxo Oncology, Inc. clinical trials

Acquired by Eli Lilly and Company, Feb 15, 2019 · source ↗

The registry lists 17 studies whose lead sponsor is Loxo Oncology, Inc.. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 4, 2026.

Before and after it joined Eli Lilly and Company

First submitted before Loxo Oncology, Inc. became part of Eli Lilly and Company
1
First submitted after Loxo Oncology, Inc. became part of Eli Lilly and Company
16
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Loxo Oncology, Inc.’s studies test, most open studies first — 3 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

2 of Loxo Oncology, Inc.’s studies under way reach primary completion within a year, all of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. 1O
  13. 1N

All 2

Add all 2 to your calendar (.ics) → With an account.

All 17 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now212%
  • Under way, not recruiting529%
  • Completed847%
  • Stopped early16%
  • Status unknown or other16%

Phase

  • Phase 18
  • Phase 36
  • Phase 23

Where

  • United States15
  • Australia8
  • Poland8
  • Korea, Republic of8
  • Italy8
  • United Kingdom8

Over the years

  1. 19
  2. 20
  3. 721
  4. 22
  5. 23
  6. 24
  7. 25
  8. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Loxo Oncology, Inc.17 studies

Something wrong with this grouping? Tell us on the Eli Lilly and Company page.

Studies

Recruiting first, then most recently updated. Showing 17 of 17. All Eli Lilly and Company studies →